Association of advanced glycation end products in Dupuytren disease
Open Access
- 7 June 2018
- journal article
- research article
- Published by Springer Nature in Journal of Orthopaedic Surgery and Research
- Vol. 13 (1) , 143
Abstract
Advanced glycation end products are associated with aging, hyperglycemia, and oxidative stress. Accumulation of advanced glycation end products can cause various pathological conditions; however, the association of Dupuytren’s disease with advanced glycation end products has not been demonstrated yet. The aim of this study is to investigate the association of Dupuytren’s disease with advanced glycation end products. Normal palmar fascia from five patients with carpal tunnel syndrome (control group) and Dupuytren’s cords from five patients (Dupuytren’s disease group) were harvested. The tissues were stained using an anti-advanced glycation end products antibody, anti-receptor for advanced glycation end products antibody, and an anti-reactive oxygen species modulator 1 antibody. The expression of nicotinamide adenine dinucleotide phosphate oxidase-1 and nicotinamide adenine dinucleotide phosphate oxidase-4 genes was also assessed using real-time PCR. For in vitro analysis, the cells harvested from the control and Dupuytren’s disease groups were used. After 3 days of exposure to four types of media (control group, control + advanced glycation end products group, Dupuytren’s disease group, Dupuytren’s disease + advanced glycation end products group), superoxide detection reagent was detected using a total reactive oxygen species/superoxide detection kit. Immunostaining of the palmar fasciae of the Dupuytren’s disease group showed higher expressions of advanced glycation end products and receptor for advanced glycation end products than that in the control group. The expression of nicotinamide adenine dinucleotide phosphate oxidase oxidase-1 and nicotinamide adenine dinucleotide phosphate oxidase-4 as well as reactive oxygen species modulator 1, an oxidatively damaged protein, was also higher in the Dupuytren’s disease group than in the control group. In an in vitro cell culture, the addition of advanced glycation end products to the Dupuytren’s disease-derived cells produced more superoxide free radicals. These data suggest that the advanced glycation end products receptor for advanced glycation end products interaction produced free radicals via nicotinamide adenine dinucleotide phosphate oxidase activation in Dupuytren’s disease patients. Further studies are required to confirm these results.Keywords
This publication has 32 references indexed in Scilit:
- Investigation of the freely available easy-to-use software ‘EZR’ for medical statisticsBone Marrow Transplantation, 2012
- An Image Analysis Method for the Precise Selection and Quantitation of Fluorescently Labeled Cellular ConstituentsJournal of Histochemistry & Cytochemistry, 2012
- Free radicals, antioxidants and functional foods: Impact on human healthPharmacognosy Reviews, 2010
- Mechanisms, Pathophysiology, and Therapy of Arterial StiffnessArteriosclerosis, Thrombosis, and Vascular Biology, 2005
- Dupuytren’s Disease Risk FactorsJournal of Hand Surgery (European Volume), 2004
- Role of Advanced Glycation End Products in Diabetic NephropathyJournal of the American Society of Nephrology, 2003
- CONNECTIVE TISSUE AND JOINT DISEASE IN DIABETES MELLITUSEndocrinology and Metabolism Clinics of North America, 1996
- PDGF and TGF-β mediate collagen production by mesangial cells exposed to advanced glycosylation end productsKidney International, 1995
- Free radicals and Dupuytren's contracture.BMJ, 1987
- Biochemistry and histology of the connective tissue of Dupuytren's disease lesionsEuropean Journal of Clinical Investigation, 1980